Header Logo

Assessing disease severity in bio-na?ve patients with RA on treatment with csDMARDs: insights from the Corrona Registry.

Harrold LR, Patel PA, Griffith J, Litman HJ, Feng H, Schlacher CA, Kremer JM. Assessing disease severity in bio-na?ve patients with RA on treatment with csDMARDs: insights from the Corrona Registry. Clin Rheumatol. 2020 Feb; 39(2):391-400.

View in: PubMed